Endometriosis and cancer: a comparative characteristic and new perspectives of treatment and prevention

L.V. Adamyan, Y.B. Aznaurova
In: Voprosy ginekologii, akušerstva i perinatologii · 2020 · vol. 19(3) , pp. 95–100 · doi:10.20953/1726-1678-2020-3-95-100 · W3082589766
article OA: closed CC0 ⤵ 1 in-corpus citation
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06+body, 2026-06-13 ⓘ

This review compares endometriosis and cancer based on risk factors, histology, pathogenesis, and stem cell roles, exploring malignant transformation and potential drug repositioning.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text ⓘ

This review compares endometriosis and cancer across risk factors, histological features, pathogenetic mechanisms, and the proposed role of stem cells, discussing criteria used to identify endometriosis-associated malignant tumors. It considers potential factors that drive malignant transformation of endometrial foci and frames similarities between the two conditions to motivate new perspectives on treatment and prevention. It further discusses the possibility of repurposing drugs that are under study for oncological diseases in light of these parallels, without providing a primary experimental dataset. This paper is centrally about endometriosis — it compares endometriosis with cancer, including endometriosis-associated malignization and perspectives such as drug repositioning.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 1,037 characters · extracted from oa-doi-fallback · click to expand
Endometriosis and cancer: a comparative characteristic and new perspectives of treatment and prevention L.V.Adamyan / Ya.B.Aznaurova / The review presents a comparative characteristic of endometriosis and cancer with respect to such parameters as risk factors, histological picture, pathogenetic aspects, the role of stem cells. The criteria of determining endometriosis-associated malignant tumours are described and potential factors of malignization of endometrial foci are considered. Taking into account the similarity of endometriosis and cancer, a possibility of repositioning the drugs that undergo studies for treatment of oncological diseases is also discussed. Key words: carcinoma, drug repositioning, stem cells, risk factors, endometriosis. For citation: Adamyan L.V., Aznaurova Ya.B. Endometriosis and cancer: a comparative characteristic and new perspectives of treatment and prevention. Vopr. ginekol. akus. perinatol. (Gynecology, Obstetrics and Perinatology). 2020; 19(3): 95–100. DOI: 10.20953/1726-1678-2020-3-95-100

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-07-30T08:32:49.343555+00:00
License: CC0 · commercial use OK